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WC have previously described a 30 kDa basic fibroblast growth factor (bFGF).like protein in rodent eslicular homogenates and have shown that 
pachytene sprmatocytes are the sites of predominant immunoreactivity for this bFGF-like protein (Mayerhofer. A.. Russell, L-D.. Grothe. C., 
Rudolf, M. and Gratzl. M. (1991) Endocrinology 129.921-924). WC have now addressed the question whether this 30 kDa bFCF-like protein is 
a large bFGF form and whether it is produced by pachylene spermalocytes. WC detected bFGF mRNA in homogenates of isolated mouse 
spermatocytes (which consisted mainly of pachytene spermatucytes) using Sl nuclei&se protection assays. As shown by Western blot analyses, the 
bFGF mRNA in mouse spermatocyles is translated into bFGF of an approximate molecular weight of 30 kDn. Neither bFGF mRNA, nor bFGF 
itself, was observed in isolated mouse Leydig cells. These results indicate that the immunoreactive bFGF-like protein observed previously in germ 
cells of the murine testis is identical to bFGF. Thus, germ cells of the testis produce bFGF, which may exert regulatory function in the process 
of spermalogcnesls. 
Basic fibroblast growth factor; Testis: Mouse; mRNA; Germ cell 
1. INTRODUCTION 
The testis is a rich source of basic fibroblast growth 
factor (bFGF) [2,3]. However, until recently the locali- 
zation of bFGF in the adult testis was unclear. We have 
previously shown that a bFGF-like protein of approxi- 
mately 30 kDa exists in rodent testes [l], Immunocyto- 
chemical procedures allowed us to localize this protein 
to germ cells in the rat and mouse testes. Thus, pa- 
chytene spermatocytes were the cells which revealed 
strongest immunoreactivity, but also some type A sper- 
matogonia and spermatides during elongation were la- 
beled [l]. Moreover, the bFGF-like immunoreactivity 
in the spermatocytes was restricted to certain develop 
mental steps (stages), where it might exert specific func- 
tions. However, from this previous study it was not 
clear whether the bFGF-like protein in testicular germ 
cells is indeed bFGF or only an immunologically related 
factor. In addition, it was known whether germ cells are 
indeed the production site for bFGF. To answer these 
urgent questions, we have examined in the present study 
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whether isolated spermatocytes contain both mRNA 
for bFGF and protein. 
2. MATERIALS AND METHODS 
?. I . Asitnafs 
Adult malt rats (Sprague-Dawley, Charles River. Sulzfeld, Ger- 
many) were killed under deep CO: anesthesia, testes were removed and 
rapidly frozen and stored frozen until isolation of RNA. Adult male 
mice (NMRI, Charles River, Earlr!al, Germany) were killed byfervi. 
cat dislocation and spermatocytes and Leydig cells were isolated from 
mouse testes. 
Isolation procedure of sprmatocytes from lhc testes of adult 
NMRI mice was based on Ihe methods of BellvC et al. [4], Wolgemuth 
et al, [S] and Djakiew and Dym [6], In brief, testes of four mice were 
decapsulated and incubated in PBS containing I m&ml collagenase 
(Worthington/Flow Laboratories, Bonn, Germany) and 2yg DNAsc 
I (Sigma, Munich, Germany) for 30 min at 34°C in a shaking water 
bath (120 cycleslmin). Isolated tubules were washed three times with 
PBS and treated with 0.25% trypiin (WorthingtonlFlow Labonito- 
ries), 2 lug DNAse I, 0.07 mg dispase (Bochringer, Mannheim, Gcr- 
many) in PBS for I5 min at 34OC. The resulting tubular fragments 
were further disrupted by repetitive pipetting (25 times) and centri- 
fugedat 140 x g for IO min. The cell pellet obtained was resuspended 
in Dulbceco’s modified Eagle’s medium (DMEM. Flow Laboralories) 
containing 0.5% bovine serum albumin (BSA, Sigmaj. Aiter cenirifu- 
gation at 50 x g for 10 min, the cell @let was resuspended in 0.5% 
BSAIDMEM and passed through a nylon mesh (70 pm-openings). 
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The cell suspension (5 x 10” celltiml) was loaded on top of a 1-496 BSA 
gradient (in PBS) in a separating funnel (I 1) at I xg and was overlayed 
with 30 ml of 0.2% BSAIPBS, After 1.5 h, SO-ml fractions were col- 
lected from the bottom of the gradient and the purest fractions of 
spcrmatocytes were pooled (judged according to their morphological 
appearance; see Fig. I). The cells were frozen (at -7OOC) and stored 
until needed for Western blotring and/or RNA isolation f(‘li SI nucle- 
ase assay. 
2.3. Iso[utQ~~ of tnousb Leydig ceils 
Mouse Leydig cells from an additional 6 adult mice were purified 
using discontinuous Percoll gradients as described previously by 
Sharpe and Fraser [7] with minor modifications, Testes were decapsu- 
lated and mechanically dispersed by repetitive pipetting in Dulbccco’s 
modified Eagle medium (DMEM; Flow Laboratories), reducing the 
diameter ofthe pipette tip successively. Undisperscd tissue and tubule 
fragments were allowed to settle and the suprnatant (Leydig cells) 
was filtered through sterile gauze and then centrifuged at 120 x 6 for 
IO min. The pellet was resuspended in glucose-enriched PBS (6 g/l; 
G-PBS) and IO ml of the cell suspension was londcd onto u discontin- 
uous gradient of Percoll (Pharmacia, Freibutg, Germany) in G-PBS. 
The gradient consisted of 3 layers (each 10 ml) with specific weights 
of 1.08, 1.06 and I,05 &ml. After centrifugation at I.100 xg for 25 
min, pure Lcydig cells accumlllated on top of the I .OE dml layer and 
were aspirated: they were washed in G-PBS (with 0.03% BSA) and 
were resuspended in culture medium (DMEM with 10% hent-inac- 
tivated fetal calf serum, 2 mM glutamine and 20 pg gentamycinlml) 
and were counted in a haemocytometer, Per animal the yields of 
Leydig cells were in the range of 5-8 x10’ cells and the purity rangcxl 
between 75-958 using 3@hydroxysteroid dehydrogenase taining [7], 
Freshly isolated cells were frozen until used for Western blotting/S1 
nuclease assay. 
2,4. Western blot unul~ws 
Spcrmatocytes and Leydig cells were thawed and sonicated in 62.5 
mM Tris-I-ICI buffer (pH 6,s) containing 10% saccharose, 5% 2. 
mercaptoethanol and 2% sodium dodccyl sulfate (SDS) and boiled for 
5 min. Western blots were described previously in detail [I]. In brief, 
proteins were separated by SDSmpolyacrylamide gel electrophoresis, 
blotted onto nitrocellulose and probed with a rabbit anti.bFGF anti- 
serum (l:SOO) [8.9]. Immunorcaction was detected after incubation 
with a biotinylated goat anti-rabbit serum (Camon, Wiesbaden, Germ 
many) using a commercial ABC kit (Vector, Burlington, CA, USA) 
and diaminobenzidine tclrahydrochloride (DAB, Aldrich, Milwaukee, 
WI) following the instructions of the manufacturer. 
2.5. Syllrltrsis L-RNA-probe. isobrbt of RNA and SI rrucfcuse protec- 
tion oswy 
The rat bFCiF 820 bp cDNA encoding the entire rat bFGF was 
cloned with additional EcoRI linkers and has been previously charac- 
terized [IO]. 
The 820 bp bFGF f?coHI iragment of this cDNA clone was sub. 
cloned in Bluescribe Ml3 (-) (Stratagene, La Jolla, CA, USA) and is 
referred to as clone bFGF (Ml 3-). As a template for cRNA synthesis 
we used the cDNA clone bFGF (Ml3-). Synthesis of 37P-labeled 
cRNA (spec. act. 3.96 x 10’ cpm&y) for SI nuclease protection assay 
(S1-SPA) was carried out according to the T7 polymerase protocol 
of Promcga Blotec (Madison, WI, USA) using 20 yCi of [a-“P]UTP 
(spec. act. 15 TBqlmmol) and 2 ,ug of bFGF (M 13-) linearized with 
Rsal. The resulting cRNA probe contained 320 nucleotides of bFGF 
(225 bp translated an;i 96 nucleotides 3’ untranslated sequences) and 
I I nucleotides of vector sequences ( ee Fig. 2A). 
2.6. Sl n&are protection nssuy (SI-NPA) wirh u lab&d cRNA- 
probe 
Total RNA was isolated by a modified guanidinium thiocyanate- 
CsCl method I1 I] from rodent testes and isolated pchytene spermam 
tocytcs (see Fig. 2B). A total OmI,Ug of RNA (determined photomet- 
rically) and controls (consisting of Hz0 or tRNA instead of total 
RNA) were hybridized with an excess of ‘!P-labeled cRNA probe (5 
x IO’cpm; spec. act. 3.96 x IO’cpml~g) for I6 h at 58°C as described 
previously [I?]. The tRNA controls were used to verify the specificity 
of S I nucleasc hydrolysis. The RNAIcRNA hybridization was termi- 
nated by digestion with 680 U S1 nuclease (AGS, Heidelberg, Ger- 
many) for 2 h at 37°C. It should be mentioned that Sl nuclcase, 
though more active in DNA hydrolysis, can also be used to hydrolyze 
single-slranded RNA templates. After phenol extraction and ethanol 
precipitation samples were separated lectrophoretically on0.3 mm- 
thick 5% polyacrylamide gels (8.3 M urea), Gels were dried and cx- 
posed to X-my films at -7OOC using intensifying screens. 
3. RESULTS 
Isolated mouse spermatocytes contained mRNA for 
bFGF, as did homogenates of whole testes of the rat 
Fig. 1 a Phase contrnst micrograph of isolated mouse spermatocytes a used for the present study. Bar = 40 pm. 
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Fig. 2. (A) Scheme of single-stranded cRNA probe used for SI nucle- 
ase protection assay. The cRNA probe (331 nucleotides) synthesized 
from cDNA bFGF M13(-) spans about one third of the whole rat 
bFGF translated and the lotal 3’ untranslated sequence. It originates 
at the 3’ end End extends towards its 5’ end up to the internal 12sul 
restriction site. The 320 nucleotide RNA fragment protccied from SI 
nuclease hydrolysis is shown. The scaffolded box corresponds to the 
3’ part of the bFGF coding region and the line to the 3’ untranslated 
sequence. The T7 promoter, the RsoI restriction site and the vector 
sequences are indicated, (B) SI nucleasc prelection analysis of ex- 
tracled total RNA of rat testis and mouse spcrmatocytes bFGF 
mRNA is prcscnt in RNA isolated from rat lestis and from mouse 
spermatocytes. Lane 3. pachytene mouse spcrmatocytes; lane 4, rat 
testis, As size marker, Hpull-digested pBR322 was applied to lane I, 
and the sizes are indicated on the left. The 331 nucleotide fragment 
in lane 2 represents undigested probe containing Ranking vector se- 
quences. The thin arrow depicts the undigested probe of 33 1 nuclco- 
tides, whereas the bold arrow corresponds to the protecled cRNA 
fragment of 320 nucleotides. 
(Fig. 2B). With Sl nuclease assays a protected band of 
336 nucleotides was yielded, indicating the presence of 
bFGF mRNA co-linear with the probe in both testicu- 
lar homogenates and isolated spermatocytes (Fig. 2B). 
No bFGF mRNA was found in isolated mouse Leydig 
cells and the tRNA control did not yield a band in the 
range of 336 nucleotides (not shown). ‘The rat bFGF 
antisel?se RNA probe could be used to detect bFGF 
mRNA in the mouse spermatocytes, although there are 
some mismatches in the RNA/mRNA hybrids. The Sl 




Fig. 3. Result of Western blot analysis. Immunorcactive bands of 
approximately 30 kDa were detected after probing blots of mous 
testis homogenates (lane I), isolated mouse spermatocytes (lane 2) 
with anti-bFGF (I 500). while no immunoreactive band was seen with 
isolated mouse Leydig cells (lane 3). 
unless there are more than three consecutive mis- 
matches [13]. 
Western blotting revealed that in mouse spermato- 
cytes mRNA is also translated into a 30 kDa form of 
bFGF, which is present in homogenates of whole mouse 
testes as well, but which cannot be detected in cultured 
mouse Leydig cells (Fig. 3). 
4. DISCUSSION 
The results of the present study extend our previous 
report on the localization of an immunoreactive 30 kDa 
bFGF-like protein in germ cells of rodent testes [l]. 
Here we now show that pachytene spermatocytes, 
which in both rat and mouse testes revealed strongest 
immunoreactivity for the bFGF-like protein, do indeed 
contain bFGF mRNA and, moreover, that bFGF 
mRNA is translated into a 30 kDa form of bFGF. 
These results, together with our previous detailed im- 
munocytochemical study, indicate that pachytene sper- 
matocytes are the main source of bFGF in the testis. 
It is known that bFGF mRNA exhibits a strong se- 
quence homology within several species. For example, 
the rat bFGF cDNA used for the present study has been 
successfully used in a taxonomically distant species, like 
Xetspus, and appears to be homologous to bFGF 
mRNA in Xcttopus oocytes and the early Xmopus em- 
bryo [l&l 51. This fact and the present results indicate 
that bFGF mRNAs in mouse and rat share a high 
sequence homology. 
It is generally assumed that bFGF is a molecule of 
approximate molecular weight of I3 kDa (see [16]). 
However, at present several higher molecular weight 
4s 
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forms of bFGF (ranging from 20-25 kDa) [ 17-191 have 
been described and a large number of bFGF im- 
munoreactive proteins are known (including 24-, 27-, 
29-, 30. atid 46-kDa_ forms [9,17,20,21]. Our results in 
the testis indicate that the 30 kDa pachytene spermato- 
cyte-derived bFGF is another genuine high molecular 
weight form of bFGF. It is presently unclear whether 
this 30 kDa form itself has biological activity, or repre- 
sents a precursor for the 1% kDa bFGF form. However, 
before this question can be addressed the target cells for 
bFGF in the testis must be identified. Becailse bFGF 
lacks a signal sequence, which is thought to mediate 
secretion [163, it is unclear how bFGF can leave the cell. 
Following secretion by spermatocytes it could act in a 
paracrine way on other cells within or maybe even out- 
side the tubular compartment. Possible candidates for 
bFGF targets are Sertoli cells. In vitro, these cells re- 
portedly respond to bFGF by expression of receptors 
for FSH or plasminogen activator [22] or by increases 
of c-fos mRNA [23]. However, it cannot be excluded 
that bFGF acts in an autocrine fashion on germ cells. 
Additional studies hould address this question in view 
of the fact that germ cells are connected by intercellular 
bridges [24]. Thus, bFGF could also influence neigh- 
bouring germ cells without reaching the extracellulal 
space. 
The germinal epithelium in the adult testis is sub. 
jetted to constant proliferation and differentiation. An 
array of locally produced growth factors (e.g. acidic 
libroblast growth factor, nerve growth factor, seminif- 
erous growth factor, insulin like-growth factor 1 and 
transforming rowth factors alpha and beta) is assumed 
to be involved in the control of these processes (see 
[2S-271). Our data indicate that germ cell-derived bFGF 
is one of these factors, which in concerted action with 
others might participate in the regulation of spermatom 
genesis. 
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